APO Research
Talk to an analyst

APO RESEARCH · REPORT

NeuN Antibody

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NeuN Antibody Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchNeuN Antibody Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal NeuN Antibody Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal NeuN Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NeuN Antibody Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal NeuN Antibody Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global NeuN Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NeuN Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NeuN Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NeuN Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NeuN Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NeuN Antibody market include Thermo Fisher Scientific, Merck, Boster Biological Technology, United States Biological, Synaptic, Proteintech, NSJ Bioreagents, Miltenyi Biotec and HUABIO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global NeuN Antibody market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NeuN Antibody and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NeuN Antibody revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global NeuN Antibody market.

NeuN Antibody Segment by Company

Thermo Fisher Scientific

Merck

Boster Biological Technology

United States Biological

Synaptic

Proteintech

NSJ Bioreagents

Miltenyi Biotec

HUABIO

GeneTex

FineTest

Cell Signaling Technology

Bioss

BioLegend

Abcam

NeuN Antibody Segment by Type

Polyclonal

Monoclonal

NeuN Antibody Segment by Application

Western Blot

Immunocytochemistry

Immunofluorescence

Immunohistochemistry

Others

NeuN Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global NeuN Antibody status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the NeuN Antibody key companies, revenue, market share, and recent developments.

3. To split the NeuN Antibody breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions NeuN Antibody market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NeuN Antibody significant trends, drivers, influence factors in global and regions.

6. To analyze NeuN Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NeuN Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NeuN Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NeuN Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NeuN Antibody industry.

Chapter 3: Detailed analysis of NeuN Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of NeuN Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of NeuN Antibody in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NeuN Antibody Industry Trends Table 2. NeuN Antibody Industry Drivers Table 3. NeuN Antibody Industry Opportunities and Challenges Table 4. NeuN Antibody Industry Restraints Table 5. Global NeuN Antibody Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NeuN Antibody Revenue Share by Company (2021-2026) Table 7. Global NeuN Antibody Company Ranking, (2024-2026) & (US$ Million) Table 8. Global NeuN Antibody Key Company Manufacturing Base & Headquarters Table 9. Global NeuN Antibody Company, Product Type & Application Table 10. Global NeuN Antibody Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global NeuN Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Polyclonal Table 15. Significant Companies of Monoclonal Table 16. Global NeuN Antibody Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global NeuN Antibody Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global NeuN Antibody Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global NeuN Antibody Sales Value Share by Type (2021-2026) Table 20. Global NeuN Antibody Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Western Blot Table 22. Significant Companies of Immunocytochemistry Table 23. Significant Companies of Immunofluorescence Table 24. Significant Companies of Immunohistochemistry Table 25. Significant Companies of Others Table 26. Global NeuN Antibody Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global NeuN Antibody Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global NeuN Antibody Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global NeuN Antibody Sales Value Share by Application (2021-2026) Table 30. Global NeuN Antibody Sales Value Share by Application (2027-2032) Table 31. Global NeuN Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global NeuN Antibody Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global NeuN Antibody Sales Value Share by Region (2021-2026) Table 34. Global NeuN Antibody Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global NeuN Antibody Sales Value Share by Region (2027-2032) Table 36. Global NeuN Antibody Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global NeuN Antibody Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global NeuN Antibody Sales Value Market Share by Country (2021-2026) Table 39. Global NeuN Antibody Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global NeuN Antibody Sales Value Market Share by Country (2027-2032) Table 41. Thermo Fisher Scientific Company Information Table 42. Thermo Fisher Scientific Business Overview Table 43. Thermo Fisher Scientific NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Thermo Fisher Scientific NeuN Antibody Product Portfolio Table 45. Thermo Fisher Scientific Recent Development Table 46. Merck Company Information Table 47. Merck Business Overview Table 48. Merck NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Merck NeuN Antibody Product Portfolio Table 50. Merck Recent Development Table 51. Boster Biological Technology Company Information Table 52. Boster Biological Technology Business Overview Table 53. Boster Biological Technology NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Boster Biological Technology NeuN Antibody Product Portfolio Table 55. Boster Biological Technology Recent Development Table 56. United States Biological Company Information Table 57. United States Biological Business Overview Table 58. United States Biological NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. United States Biological NeuN Antibody Product Portfolio Table 60. United States Biological Recent Development Table 61. Synaptic Company Information Table 62. Synaptic Business Overview Table 63. Synaptic NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Synaptic NeuN Antibody Product Portfolio Table 65. Synaptic Recent Development Table 66. Proteintech Company Information Table 67. Proteintech Business Overview Table 68. Proteintech NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Proteintech NeuN Antibody Product Portfolio Table 70. Proteintech Recent Development Table 71. NSJ Bioreagents Company Information Table 72. NSJ Bioreagents Business Overview Table 73. NSJ Bioreagents NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. NSJ Bioreagents NeuN Antibody Product Portfolio Table 75. NSJ Bioreagents Recent Development Table 76. Miltenyi Biotec Company Information Table 77. Miltenyi Biotec Business Overview Table 78. Miltenyi Biotec NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Miltenyi Biotec NeuN Antibody Product Portfolio Table 80. Miltenyi Biotec Recent Development Table 81. HUABIO Company Information Table 82. HUABIO Business Overview Table 83. HUABIO NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. HUABIO NeuN Antibody Product Portfolio Table 85. HUABIO Recent Development Table 86. GeneTex Company Information Table 87. GeneTex Business Overview Table 88. GeneTex NeuN Antibody Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. GeneTex NeuN Antibody Product Portfolio Table 90. GeneTex Recent Development Table 91. FineTest Company Information Table 92. FineTest Business Overview Table 93. FineTest NeuN Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. FineTest NeuN Antibody Product Portfolio Table 95. FineTest Recent Development Table 96. Cell Signaling Technology Company Information Table 97. Cell Signaling Technology Business Overview Table 98. Cell Signaling Technology NeuN Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cell Signaling Technology NeuN Antibody Product Portfolio Table 100. Cell Signaling Technology Recent Development Table 101. Bioss Company Information Table 102. Bioss Business Overview Table 103. Bioss NeuN Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bioss NeuN Antibody Product Portfolio Table 105. Bioss Recent Development Table 106. BioLegend Company Information Table 107. BioLegend Business Overview Table 108. BioLegend NeuN Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. BioLegend NeuN Antibody Product Portfolio Table 110. BioLegend Recent Development Table 111. Abcam Company Information Table 112. Abcam Business Overview Table 113. Abcam NeuN Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Abcam NeuN Antibody Product Portfolio Table 115. Abcam Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. NeuN Antibody Product Image Figure 2. Global NeuN Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NeuN Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global NeuN Antibody Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Polyclonal Image Figure 8. Monoclonal Image Figure 9. Global NeuN Antibody Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global NeuN Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global NeuN Antibody Sales Value Share by Type (2021-2032) Figure 12. Western Blot Image Figure 13. Immunocytochemistry Image Figure 14. Immunofluorescence Image Figure 15. Immunohistochemistry Image Figure 16. Others Image Figure 17. Global NeuN Antibody Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global NeuN Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global NeuN Antibody Sales Value Share by Application (2021-2032) Figure 20. Global NeuN Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global NeuN Antibody Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America NeuN Antibody Sales Value (2021-2032) & (US$ Million) Figure 23. North America NeuN Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe NeuN Antibody Sales Value (2021-2032) & (US$ Million) Figure 25. Europe NeuN Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific NeuN Antibody Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific NeuN Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America NeuN Antibody Sales Value (2021-2032) & (US$ Million) Figure 29. South America NeuN Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa NeuN Antibody Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa NeuN Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt NeuN Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt NeuN Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt NeuN Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Western Blot
  • Immunocytochemistry
  • Immunofluorescence
  • Immunohistochemistry
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Boster Biological Technology
  • United States Biological
  • Synaptic
  • Proteintech
  • NSJ Bioreagents
  • Miltenyi Biotec
  • HUABIO
  • GeneTex
  • FineTest
  • Cell Signaling Technology
  • Bioss
  • BioLegend
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NeuN Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NeuN Antibody Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 NeuN Antibody Market Dynamics
  1. 2.1 NeuN Antibody Industry Trends
  2. 2.2 NeuN Antibody Industry Drivers
  3. 2.3 NeuN Antibody Industry Opportunities and Challenges
  4. 2.4 NeuN Antibody Industry Restraints
3 NeuN Antibody Market by Company
  1. 3.1 Global NeuN Antibody Company Revenue Ranking in 2025
  2. 3.2 Global NeuN Antibody Revenue by Company (2021-2026)
  3. 3.3 Global NeuN Antibody Company Ranking (2024-2026)
  4. 3.4 Global NeuN Antibody Company Manufacturing Base and Headquarters
  5. 3.5 Global NeuN Antibody Company Product Type and Application
  6. 3.6 Global NeuN Antibody Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global NeuN Antibody Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 NeuN Antibody Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 NeuN Antibody Market by Type
  1. 4.1 NeuN Antibody Type Introduction
  2. 4.1.1 Polyclonal
  3. 4.1.2 Monoclonal
  4. 4.2 Global NeuN Antibody Sales Value by Type
  5. 4.2.1 Global NeuN Antibody Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NeuN Antibody Sales Value by Type (2021-2032)
  7. 4.2.3 Global NeuN Antibody Sales Value Share by Type (2021-2032)
5 NeuN Antibody Market by Application
  1. 5.1 NeuN Antibody Application Introduction
  2. 5.1.1 Western Blot
  3. 5.1.2 Immunocytochemistry
  4. 5.1.3 Immunofluorescence
  5. 5.1.4 Immunohistochemistry
  6. 5.1.5 Others
  7. 5.2 Global NeuN Antibody Sales Value by Application
  8. 5.2.1 Global NeuN Antibody Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global NeuN Antibody Sales Value by Application (2021-2032)
  10. 5.2.3 Global NeuN Antibody Sales Value Share by Application (2021-2032)
6 NeuN Antibody Regional Value Analysis
  1. 6.1 Global NeuN Antibody Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NeuN Antibody Sales Value by Region (2021-2032)
  3. 6.2.1 Global NeuN Antibody Sales Value by Region: 2021-2026
  4. 6.2.2 Global NeuN Antibody Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NeuN Antibody Sales Value (2021-2032)
  7. 6.3.2 North America NeuN Antibody Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe NeuN Antibody Sales Value (2021-2032)
  10. 6.4.2 Europe NeuN Antibody Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific NeuN Antibody Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific NeuN Antibody Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America NeuN Antibody Sales Value (2021-2032)
  16. 6.6.2 South America NeuN Antibody Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa NeuN Antibody Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa NeuN Antibody Sales Value Share by Country, 2025 VS 2032
7 NeuN Antibody Country-level Value Analysis
  1. 7.1 Global NeuN Antibody Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NeuN Antibody Sales Value by Country (2021-2032)
  3. 7.2.1 Global NeuN Antibody Sales Value by Country (2021-2026)
  4. 7.2.2 Global NeuN Antibody Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA NeuN Antibody Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada NeuN Antibody Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico NeuN Antibody Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany NeuN Antibody Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France NeuN Antibody Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. NeuN Antibody Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy NeuN Antibody Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain NeuN Antibody Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia NeuN Antibody Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands NeuN Antibody Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries NeuN Antibody Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China NeuN Antibody Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan NeuN Antibody Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea NeuN Antibody Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India NeuN Antibody Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia NeuN Antibody Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia NeuN Antibody Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil NeuN Antibody Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina NeuN Antibody Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile NeuN Antibody Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia NeuN Antibody Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru NeuN Antibody Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia NeuN Antibody Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel NeuN Antibody Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE NeuN Antibody Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey NeuN Antibody Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran NeuN Antibody Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran NeuN Antibody Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt NeuN Antibody Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt NeuN Antibody Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt NeuN Antibody Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific NeuN Antibody Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific NeuN Antibody Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck NeuN Antibody Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck NeuN Antibody Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Boster Biological Technology
  14. 8.3.1 Boster Biological Technology Company Information
  15. 8.3.2 Boster Biological Technology Business Overview
  16. 8.3.3 Boster Biological Technology NeuN Antibody Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boster Biological Technology NeuN Antibody Product Portfolio
  18. 8.3.5 Boster Biological Technology Recent Developments
  19. 8.4 United States Biological
  20. 8.4.1 United States Biological Company Information
  21. 8.4.2 United States Biological Business Overview
  22. 8.4.3 United States Biological NeuN Antibody Revenue and Gross Margin (2021-2026)
  23. 8.4.4 United States Biological NeuN Antibody Product Portfolio
  24. 8.4.5 United States Biological Recent Developments
  25. 8.5 Synaptic
  26. 8.5.1 Synaptic Company Information
  27. 8.5.2 Synaptic Business Overview
  28. 8.5.3 Synaptic NeuN Antibody Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Synaptic NeuN Antibody Product Portfolio
  30. 8.5.5 Synaptic Recent Developments
  31. 8.6 Proteintech
  32. 8.6.1 Proteintech Company Information
  33. 8.6.2 Proteintech Business Overview
  34. 8.6.3 Proteintech NeuN Antibody Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Proteintech NeuN Antibody Product Portfolio
  36. 8.6.5 Proteintech Recent Developments
  37. 8.7 NSJ Bioreagents
  38. 8.7.1 NSJ Bioreagents Company Information
  39. 8.7.2 NSJ Bioreagents Business Overview
  40. 8.7.3 NSJ Bioreagents NeuN Antibody Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NSJ Bioreagents NeuN Antibody Product Portfolio
  42. 8.7.5 NSJ Bioreagents Recent Developments
  43. 8.8 Miltenyi Biotec
  44. 8.8.1 Miltenyi Biotec Company Information
  45. 8.8.2 Miltenyi Biotec Business Overview
  46. 8.8.3 Miltenyi Biotec NeuN Antibody Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Miltenyi Biotec NeuN Antibody Product Portfolio
  48. 8.8.5 Miltenyi Biotec Recent Developments
  49. 8.9 HUABIO
  50. 8.9.1 HUABIO Company Information
  51. 8.9.2 HUABIO Business Overview
  52. 8.9.3 HUABIO NeuN Antibody Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HUABIO NeuN Antibody Product Portfolio
  54. 8.9.5 HUABIO Recent Developments
  55. 8.10 GeneTex
  56. 8.10.1 GeneTex Company Information
  57. 8.10.2 GeneTex Business Overview
  58. 8.10.3 GeneTex NeuN Antibody Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GeneTex NeuN Antibody Product Portfolio
  60. 8.10.5 GeneTex Recent Developments
  61. 8.11 FineTest
  62. 8.11.1 FineTest Company Information
  63. 8.11.2 FineTest Business Overview
  64. 8.11.3 FineTest NeuN Antibody Revenue and Gross Margin (2021-2026)
  65. 8.11.4 FineTest NeuN Antibody Product Portfolio
  66. 8.11.5 FineTest Recent Developments
  67. 8.12 Cell Signaling Technology
  68. 8.12.1 Cell Signaling Technology Company Information
  69. 8.12.2 Cell Signaling Technology Business Overview
  70. 8.12.3 Cell Signaling Technology NeuN Antibody Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cell Signaling Technology NeuN Antibody Product Portfolio
  72. 8.12.5 Cell Signaling Technology Recent Developments
  73. 8.13 Bioss
  74. 8.13.1 Bioss Company Information
  75. 8.13.2 Bioss Business Overview
  76. 8.13.3 Bioss NeuN Antibody Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bioss NeuN Antibody Product Portfolio
  78. 8.13.5 Bioss Recent Developments
  79. 8.14 BioLegend
  80. 8.14.1 BioLegend Company Information
  81. 8.14.2 BioLegend Business Overview
  82. 8.14.3 BioLegend NeuN Antibody Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BioLegend NeuN Antibody Product Portfolio
  84. 8.14.5 BioLegend Recent Developments
  85. 8.15 Abcam
  86. 8.15.1 Abcam Company Information
  87. 8.15.2 Abcam Business Overview
  88. 8.15.3 Abcam NeuN Antibody Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abcam NeuN Antibody Product Portfolio
  90. 8.15.5 Abcam Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst